Lifecore Biomedical, Inc. \De\ (LFCR) FCF Margin (2010 - 2025)
Lifecore Biomedical, Inc. \De\ (LFCR) posted quarterly FCF Margin of 8.92% for Q2 2025, down 693.0% year-over-year from 1.5% in Q2 2024, and up 173.64% quarter-over-quarter from 12.11% in Q1 2025.
Lifecore Biomedical, Inc. \De\ (LFCR) FCF Margin (2010 - 2025) Analysis & Trends
Lifecore Biomedical, Inc. \De\'s FCF Margin history runs 16 years deep, the most recent figure standing at 8.92% for Q2 2025.
- In Q2 2025, FCF Margin fell 693.0% year-over-year to 8.92%; the TTM figure through May 2025 stood at 10.57% (up 357.0% YoY), while the FY2025 annual figure was 10.57%, up 357.0% from the prior year.
- FCF Margin for Q2 2025 stood at 8.92%, up from 12.11% in the prior quarter.
- The five-year high for FCF Margin was 27.9% in Q2 2021, with the low at 66.04% in Q1 2022.
- The 5-year median for FCF Margin is 29.03% (2021), against an average of 26.49%.
- The sharpest annual moves came in 2021 and 2024: FCF Margin plunged 10337 bps in 2021, then surged 7950 bps in 2024.
- Lifecore Biomedical, Inc. \De\'s FCF Margin stood at 39.98% in 2021, then advanced by 16 bps to 33.48% in 2022, then soared by 71 bps to 9.86% in 2023, then tumbled by 167 bps to 26.35% in 2024, then jumped by 134 bps to 8.92% in 2025.
- Business Quant data shows LFCR's FCF Margin at 8.92% in Q2 2025, 12.11% in Q1 2025, and 26.35% in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 25, 2025 | 8.92% |
| Feb 23, 2025 | -12.11% |
| Nov 24, 2024 | -26.35% |
| Aug 25, 2024 | -16.33% |
| May 26, 2024 | 15.84% |
| Feb 25, 2024 | -21.80% |
| Nov 26, 2023 | -9.86% |
| Aug 27, 2023 | -54.58% |
| May 28, 2023 | -63.66% |
| Feb 26, 2023 | -31.78% |
| Nov 27, 2022 | -33.48% |
| Aug 28, 2022 | -14.10% |
| May 29, 2022 | -42.51% |
| Feb 27, 2022 | -66.04% |
| Nov 28, 2021 | -39.98% |
| Aug 29, 2021 | -31.72% |
| May 30, 2021 | 27.90% |
| Feb 28, 2021 | -65.17% |
| Nov 29, 2020 | 4.59% |
| Aug 30, 2020 | 71.66% |